Cited by 110Schizophrenia research and treatmentNeuroendocrine regulation and behaviorNeurotransmitter Receptor Influence on Behavior

The DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.

A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia

Open access

Feifel, David, Shilling, Paul D., MacDonald, Kai·2016·Biological Psychiatry

DOI 10.1016/j.biopsych.2015.07.025PMC PMC5673255

Open this paper in CoChat — free account

Abstract

Schizophrenia is a disabling, heterogeneous disorder with clinical features that can be parsed into three domains: positive symptoms, negative symptoms, and cognitive deficits. Current antipsychotic drugs produce fairly robust clinical benefit against positive symptoms but typically have minimal therapeutic effects on negative symptoms and cognitive deficits. Oxytocin (OT) is a nonapeptide that, in addition to its role as a hormone regulating peripheral reproductive-relevant functions, acts as a neurotransmitter in the brain. Several lines of preclinical and clinical research suggest that the OT system may play a role in regulating the expression of schizophrenia spectrum disorders and that targeting the central OT system may yield novel treatments to address these symptoms. In this review, we summarize the extant preclinical and clinical evidence relevant to the role of OT in schizophrenia with particular emphasis on its putative therapeutic effects on each of the three above-mentioned clinical domains.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.biopsych.2015.07.025

Cites

131 of 131 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Oxytocin increases trust in humans
Kosfeld, M., Heinrichs, M., Zak, P. J., Fischbacher, U., & Fehr, E. (2005) · Nature · doi:10.1038/nature03701 · Cited by 3,690
Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review
Geyer, M. A., Krebs-Thomson, K., Braff, D. L., & Swerdlow, N. R. (2001) · Psychopharmacology · doi:10.1007/s002130100811 · Cited by 1,484
The Neuropsychopharmacology of Phencyclidine From NMDA Receptor Hypofunction to the Dopamine Hypothesis of Schizophrenia
Jentsch, J. D. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00060-8 · Cited by 1,329
Sensorimotor Gating and Schizophrenia
Braff, D. L. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810140081011 · Cited by 1,312
The NIMH-MATRICS Consensus Statement on Negative Symptoms
Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006) · Schizophrenia Bulletin · doi:10.1093/schbul/sbj053 · Cited by 1,311
Oxytocin shapes the neural circuitry of trust and trust adaptation in humans
Baumgartner, T., Heinrichs, M., Vonlanthen, A., Fischbacher, U., & Fehr, E. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.009 · Cited by 1,258
Social amnesia in mice lacking the oxytocin gene
Ferguson, J. N., Young, L. J., Hearn, E. F., Matzuk, M. M., Insel, T. R., & Winslow, J. T. (2000) · Nature Genetics · doi:10.1038/77040 · Cited by 1,130
Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse
Ferguson, J. N., Aldag, J. M., Insel, T. R., & Young, L. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-20-08278.2001 · Cited by 1,043
Dendritic peptide release and peptide-dependent behaviours
Ludwig, M., & Leng, G. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1845 · Cited by 945
Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice
Takayanagi, Y., Yoshida, M., Bielsky, I. F., Ross, H. E., Kawamata, M., Onaka, T., Yanagisawa, T., Kimura, T., Matzuk, M. M., Young, L. J., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505312102 · Cited by 806

Show all 132 references

Sorted by citations

Advances in the field of intranasal oxytocin research: lessons learned and future directions for clinical research
Quintana, D. S., Lischke, A., Grace, S., Scheele, D., Ma, Y., & Becker, B. (2021) · Molecular Psychiatry · doi:10.1038/s41380-020-00864-7 · Cited by 263
Comparative Perspectives on Oxytocin and Vasopressin Receptor Research in Rodents and Primates: Translational Implications
Freeman, S. M., & Young, L. J. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12382 · Cited by 196
“Clinical trials are in progress that aim to explore the therapeutic potential of OT in ASD (67,69), and considerable work is being carried out to examine its potential use to treat schizophrenia as well (70).”
Background
Brain oxytocin: how puzzle stones from animal studies translate into psychiatry
Grinevich, V., & Neumann, I. D. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0802-9 · Cited by 201
Treatment of negative symptoms: Where do we stand, and where do we go?
Aleman, A., Lincoln, T. M., Bruggeman, R., Melle, I. S., Arends, J., Arango, C., & Knegtering, H. (2016) · Schizophrenia Research · doi:10.1016/j.schres.2016.05.015 · Cited by 177
Vascular RAGE transports oxytocin into the brain to elicit its maternal bonding behaviour in mice
Yamamoto, Y., Liang, M., Munesue, S., Deguchi, K., Harashima, A., Furuhara, K., Yuhi, T., Zhong, J., Akther, S., Goto, H., et al. (2019) · Communications Biology · doi:10.1038/s42003-019-0325-6 · Cited by 171
Treating Negative Symptoms in Schizophrenia: an Update
Remington, G. J., Foussias, G., Fervaha, G., Agid, O., Takeuchi, H., Lee, J., & Hahn, M. (2016) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-016-0075-8 · Cited by 167
Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know
Busnelli, M., & Chini, B. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_6 · Cited by 168
Attachment, Neurobiology, and Mentalizing along the Psychosis Continuum
Debbané, M., Salaminios, G., Luyten, P., Badoud, D., Armando, M., Solida-Tozzi, A., Fonagy, P., & Brent, B. K. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00406 · Cited by 177
Oxytocin and social functioning
Jones, C., Barrera, I., Brothers, S., Ring, R., & Wahlestedt, C. (2017) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2017.19.2/cjones · Cited by 132
Overview of human oxytocin research
Kendrick, K. M., Guastella, A. J., & Becker, B. (2017) · Current Topics in Behavioral Neurosciences · doi:10.1007/7854_2017_19 · Cited by 121
Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward
Bradley, E., & Woolley, J. D. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.05.007 · Cited by 92
Naringin and Naringenin Polyphenols in Neurological Diseases: Understandings from a Therapeutic Viewpoint
Emran, T. B., Islam, F., Nath, N., Sutradhar, H., Das, R. C., Mitra, S., Alshahrani, M. M., Alhasaniah, A. H., & Sharma, R. (2022) · Life · doi:10.3390/life13010099 · Cited by 86
Potential of Oxytocin in the Treatment of Schizophrenia
Shilling, P. D., & Feifel, D. (2016) · CNS Drugs · doi:10.1007/s40263-016-0315-x · Cited by 84
Self-citation
Oxytocin and behavior: lessons from knockout mice
Caldwell, H. K., Aulino, E. A., Freeman, A. R., Miller, T. V., & Witchey, S. K. (2017) · Developmental Neurobiology · doi:10.1002/dneu.22431 · Cited by 79
Intranasal Oxytocin May Improve High-Level Social Cognition in Schizophrenia, But Not Social Cognition or Neurocognition in General: A Multilevel Bayesian Meta-analysis
Bürkner, P., Williams, D. R., Simmons, T. C., & Woolley, J. D. (2017) · Schizophrenia Bulletin · doi:10.1093/schbul/sbx053 · Cited by 82
Carbetocin is a Functional Selective Gq Agonist That Does Not Promote Oxytocin Receptor Recycling After Inducing β‐Arrestin‐Independent Internalisation
Passoni, I. P., Leonzino, M., Gigliucci, V., Chini, B., & Busnelli, M. (2016) · Journal of Neuroendocrinology · doi:10.1111/jne.12363 · Cited by 76
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
Goh, K. K., Chen, C.-H., & Lane, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042146 · Cited by 84
Oxytocin reversed MK-801-induced social interaction and aggression deficits in zebrafish
Zimmermann, F. F., Gaspary, K. V., Siebel, A. M., & Bonan, C. D. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.05.059 · Cited by 81
Personalized medicine in psychiatry
Wium‐Andersen, I. K., Vinberg, M., Kessing, L. V., & McIntyre, R. S. (2016) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2016.1216163 · Cited by 95
Exogenous effects of oxytocin in five psychiatric disorders: a systematic review, meta-analyses and a personalized approach through the lens of the social salience hypothesis
Peled‐Avron, L., Abu-Akel, A. M., & Shamay‐Tsoory, S. (2020) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2020.04.023 · Cited by 79
Lifespan oxytocin signaling: Maturation, flexibility, and stability in newborn, adolescent, and aged brain
Sannino, S., Chini, B., & Grinevich, V. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22450 · Cited by 72
Oxytocin and Serotonin Brain Mechanisms in the Nonhuman Primate
Lefèvre, A., Richard, N., Jazayeri, M., Beuriat, P.-A., Fieux, S., Zimmer, L., Duhamel, J., & Sirigu, A. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0659-17.2017 · Cited by 73
Chronic oxytocin administration as a tool for investigation and treatment: A cross-disciplinary systematic review
Horta, M., Kaylor, K., Feifel, D., & Ebner, N. C. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.10.012 · Cited by 63
Self-citation
Oxytocin attenuates phencyclidine hyperactivity and increases social interaction and nucleus accumben dopamine release in rats
Kohli, S., King, M. V., Williams, S. A., Edwards, A., Ballard, T. M., Steward, L. J., Alberati, D., & Fone, K. C. F. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0171-0 · Cited by 61
DNA Methylation and Schizophrenia: Current Literature and Future Perspective
Magwai, T., Shangase, K. B., Oginga, F. O., Chiliza, B., Mpofana, T., & Xulu, K. R. (2021) · Cells · doi:10.3390/cells10112890 · Cited by 68
Effects of intranasal oxytocin on symptoms of schizophrenia: A multivariate Bayesian meta-analysis
Williams, D. R., & Bürkner, P. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.10.013 · Cited by 58
Oxytocin differentially modulates specific dorsal and ventral striatal functional connections with frontal and cerebellar regions
Zhao, Z., Ma, X., Geng, Y., Zhao, W., Zhou, F., Wang, J., Markett, S. A., Biswal, B. B., Ma, Y., Kendrick, K. M., et al. (2018) · NeuroImage · doi:10.1016/j.neuroimage.2018.09.067 · Cited by 56
A 12-week randomized controlled trial of twice-daily intranasal oxytocin for social cognitive deficits in people with schizophrenia
Jarskog, L. F., Pedersen, C. A., Johnson, J. L., Hamer, R. M., Rau, S. W., Elliott, T., & Penn, D. L. (2017) · Schizophrenia Research · doi:10.1016/j.schres.2017.01.008 · Cited by 56
Intranasal oxytocin administration promotes emotional contagion and reduces aggression in a mouse model of callousness
Zoratto, F., Sbriccoli, M., Martinelli, A., Glennon, J. C., Macrı̀, S., & Laviola, G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.010 · Cited by 53
Naringenin: its chemistry and roles in neuroprotection
Atoki, A. V., Aja, P. M., Shinkafi, T. S., Ondari, E. N., & Awuchi, C. G. (2023) · Nutritional Neuroscience · doi:10.1080/1028415x.2023.2243089 · Cited by 47
Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats
Kozela, E., Krawczyk, M., Kos, T., Juknat, A., Vogel, Z., & Popik, P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01831-2 · Cited by 45
Potential therapeutic antipsychotic effects of Naringin against ketamine-induced deficits in rats: Involvement of Akt/GSK-3β and Wnt/β-catenin signaling pathways
George, M. Y., Menze, E. T., Esmat, A., Tadros, M. G., & El‐Demerdash, E. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117535 · Cited by 43
Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates
Galbusera, A., Felice, A. D., Girardi, S., Bassetto, G., Maschietto, M., Nishimori, K., Chini, B., Papaleo, F., Vassanelli, S., & Gozzi, A. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.283 · Cited by 38
Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies
Potasiewicz, A., Hołuj, M., Litwa, E., Gzieło, K., Socha, L., Popik, P., & Nikiforuk, A. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108040 · Cited by 39
Understanding the Oxytocin System and Its Relevance to Psychiatry
Shamay‐Tsoory, S., & Young, L. J. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.10.014 · Cited by 39
Reduced DNA Methylation of the Oxytocin Receptor Gene Is Associated With Anhedonia-Asociality in Women With Recent-Onset Schizophrenia and Ultra-high Risk for Psychosis
Bang, M., Kang, J. I., Kim, S. J., Park, J. Y., Kim, K. R., Lee, S. Y., Park, K., Lee, E. M., Lee, S., & An, S. K. (2019) · Schizophrenia Bulletin · doi:10.1093/schbul/sbz016 · Cited by 39
Role of neurotransmitters in schizophrenia: a comprehensive study
Bansal, V., & Chatterjee, I. (2021) · Kuwait Journal of Science · doi:10.48129/kjs.v48i2.9264 · Cited by 38
Trauma, Mothering, and Intergenerational Transmission: A Synthesis of Behavioral and Oxytocin Research
Kim, S., & Strathearn, L. (2017) · The Psychoanalytic Study of the Child · doi:10.1080/00797308.2016.1277897 · Cited by 38
Intranasal oxytocin increases facial expressivity, but not ratings of trustworthiness, in patients with schizophrenia and healthy controls
Woolley, J. D., Chuang, B., Fussell, C., Scherer, S. J., Biagianti, B., Fulford, D., Mathalon, D. H., & Vinogradov, S. (2017) · Psychological Medicine · doi:10.1017/s0033291716003433 · Cited by 36
Decreased Serum Oxytocin and Increased Homocysteine in First-Episode Schizophrenia Patients
Liu, Y., Tao, H., Yang, X., Huang, K., Zhang, X., & Li, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00217 · Cited by 32
Oxytocin to modulate emotional processing in schizophrenia: A randomized, double-blind, cross-over clinical trial
Brambilla, M., Cotelli, M., Manenti, R., Dagani, J., Sisti, D., Rocchi, M., Balestrieri, M., Pini, S., Raimondi, S., Saviotti, F. M., et al. (2016) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2016.08.001 · Cited by 32
Effects of oxytocin on empathy, introspective accuracy, and social symptoms in schizophrenia: A 12-week twice-daily randomized controlled trial
Halverson, T. F., Jarskog, L. F., Pedersen, C. A., & Penn, D. L. (2018) · Schizophrenia Research · doi:10.1016/j.schres.2018.09.013 · Cited by 31
Design of Oxytocin Analogs
Wiśniewski, K. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9504-2_11 · Cited by 30
Role of Oxytocin in Different Neuropsychiatric, Neurodegenerative, and Neurodevelopmental Disorders
Ghazy, A. A., Soliman, O., Elbahnasi, A. I., Alawy, A. Y., Mansour, A. M., & Gowayed, M. A. (2022) · Reviews of physiology, biochemistry and pharmacology · doi:10.1007/112_2022_72 · Cited by 27
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis
Davies, C., Paloyelis, Y., Rutigliano, G., Cappucciati, M., Micheli, A. D., Ramella‐Cravaro, V., Provenzani, U., Antoniades, M., Modinos, G., Oliver, D., et al. (2019) · Neuropsychopharmacology · doi:10.1038/s41386-018-0311-6 · Cited by 28
Prosocial effects of an oxytocin metabolite, but not synthetic oxytocin receptor agonists, in a mouse model of autism
Moy, S. S., Teng, B. L., Nikolova, V. D., Riddick, N. V., Simpson, C. D., Deusen, A. L. V., Janzen, W. P., Sassano, M. F., Pedersen, C. A., & Jarstfer, M. B. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.10.036 · Cited by 26
Social motivation in schizophrenia: The impact of oxytocin on vigor in the context of social and nonsocial reinforcement.
Fulford, D., Treadway, M. T., & Woolley, J. D. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000320 · Cited by 26
Oxytocin and Human Evolution
Carter, C. S. (2017) · Current topics in behavioral neurosciences · doi:10.1007/7854_2017_18 · Cited by 27
Peripheral oxytocin is inversely correlated with cognitive, but not emotional empathy in schizophrenia
Montag, C., Schöner, J., Speck, L. G., Just, S. A., Stuke, F., Rentzsch, J., Gallinat, J., & Majić, T. (2020) · PLoS ONE · doi:10.1371/journal.pone.0231257 · Cited by 23
Oxytocin levels in individuals with schizophrenia are high in cerebrospinal fluid but low in serum: A systematic review and meta-analysis
Hernández‐Díaz, Y., González‐Castro, T. B., Tovilla‐Zárate, C. A., López‐Narváez, M. L., Mendoza, A. D. G., Castillo-Ávila, R. G., Ramos-Méndez, M. Á., & Juárez‐Rojop, I. E. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-021-00836-y · Cited by 21
The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance
Hidalgo‐Figueroa, M., Salazar, A., Romero-López-Alberca, C., MacDowell, K. S., García‐Bueno, B., Bioque, M., Bernardo, M., Parellada, M., González-Pinto, A. M., García‐Portilla, M. P., et al. (2022) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyac023 · Cited by 20
Esquizofrenia: O Que o Médico Não Psiquiatra Precisa de Saber
Queirós, T. P., Coelho, F., Linhares, L., & Telles‐Correia, D. (2019) · Acta Médica Portuguesa · doi:10.20344/amp.10768 · Cited by 20
Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia
Bernstein, H., Müller, S., Dobrowolny, H., Wolke, C., Lendeckel, U., Bukowska, A., Keilhoff, G., Becker, A., Trübner, K., Steiner, J. H., et al. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0757-7 · Cited by 19
Intranasal oxytocin enhances EEG mu rhythm desynchronization during execution and observation of social action: An exploratory study
Festante, F., Ferrari, P. F., Thorpe, S., Buchanan, R. W., & Fox, N. A. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.104467 · Cited by 19
Oxytocin in dorsal hippocampus facilitates auditory fear memory extinction in rats
Bazaz, A., Ghanbari, A., Vafaei, A. A., Khaleghian, A., & Rashidy‐Pour, A. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108844 · Cited by 19
Unaltered Oxytocin and Vasopressin Plasma Levels in Patients with Schizophrenia After 4 Months of Daily Treatment with Intranasal Oxytocin
Busnelli, M., Dagani, J., de Girolamo, G., Balestrieri, M., Pini, S., Saviotti, F. M., Scocco, P., Sisti, D., Rocchi, M., & Chini, B. (2015) · Journal of Neuroendocrinology · doi:10.1111/jne.12359 · Cited by 19
Phosphorylation-dependent positive feedback on the oxytocin receptor through the kinase PKD1 contributes to long-term social memory
Wang, F., Yin, X.-S., Lu, J., Cen, C., & Wang, Y. (2022) · Science Signaling · doi:10.1126/scisignal.abd0033 · Cited by 15
Relationship between the domains of theory of mind, social dysfunction, and oxytocin in schizophrenia
Goh, K. K., & Lu, M. (2022) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2022.09.013 · Cited by 18
Linking childhood trauma to the psychopathology of schizophrenia: the role of oxytocin
Chen, Y.-J., Lu, M., Chiu, Y.-H., Chen, C., Santos, V. H. J., & Goh, K. K. (2024) · Schizophrenia · doi:10.1038/s41537-024-00433-9 · Cited by 19
Peptide synthesis: a review of classical and emerging methods
Cai, Z. Y., Liu, L., Zou, C. H., Jiang, X. P., Wang, G., He, X. J., Zhuang, W., Yang, C., Yao, Y., Sun, X., et al. (2025) · Biofabrication · doi:10.1088/1758-5090/ae1bdc · Cited by 17
Endogenous oxytocin response to film scenes of attachment and loss is pronounced in schizophrenia
Speck, L. G., Schöner, J., Bermpohl, F., Heinz, A., Gallinat, J., Majić, T., & Montag, C. (2018) · Social Cognitive and Affective Neuroscience · doi:10.1093/scan/nsy110 · Cited by 14
Oxytocin Receptor (OXTR) Methylation and Cognition in Psychotic Disorders
Grove, T. B., Burghardt, K. J., Kraal, A. Z., Dougherty, R. J., Taylor, S. F., & Ellingrod, V. L. (2016) · Complex Psychiatry · doi:10.1159/000448173 · Cited by 15
Intranasal oxytocin modulates higher order social cognition in body dysmorphic disorder
Fang, A., Lawson, E. A., & Wilhelm, S. (2019) · Depression and Anxiety · doi:10.1002/da.22876 · Cited by 14
The importance of pro-social processing, and ameliorating dysfunction in schizophrenia. An FMRI study of oxytocin
Wigton, R. L., Tracy, D. K., Verneuil, T., Johns, M., White, T. P., Michalopoulou, P. G., Averbeck, B. B., & Shergill, S. S. (2021) · Schizophrenia Research Cognition · doi:10.1016/j.scog.2021.100221 · Cited by 14
Binding Characteristics of Two Oxytocin Variants and Vasopressin at Oxytocin Receptors from Four Primate Species with Different Social Behavior Patterns
Taylor, J. H., Schulte, N. A., French, J. A., & Toews, M. L. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.250852 · Cited by 14
Contribution of oxytocin receptor polymorphisms to amygdala activation in schizophrenia spectrum disorders
Haram, M., Bettella, F., Brandt, C. L., Quintana, D. S., Nerhus, M., Bjella, T., Djurovic, S., Westlye, L. T., Andreassen, O. A., Melle, I., et al. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.116.003376 · Cited by 13
The implications of hypothalamic abnormalities for schizophrenia
Bernstein, H., Keilhoff, G., & Steiner, J. (2021) · Handbook of clinical neurology · doi:10.1016/b978-0-12-819973-2.00008-3 · Cited by 11
The Time Course of Dorsal and Rostral-Ventral Anterior Cingulate Cortex Activity in the Emotional Stroop Experiment Reveals Valence and Arousal Aberrant Modulation in Patients with Schizophrenia
Feroz, F. S., Leicht, G., Rauh, J., & Mulert, C. (2018) · Brain Topography · doi:10.1007/s10548-018-0677-0 · Cited by 14
Acute oxytocin effects in inferring others’ beliefs and social emotions in people at clinical high risk for psychosis
Schmidt, A., Davies, C., Paloyelis, Y., Meyer, N., Micheli, A. D., Ramella‐Cravaro, V., Provenzani, U., Aoki, Y. Y., Rutigliano, G., Cappucciati, M., et al. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00885-4 · Cited by 14
Symptomatic thinking: the current state of Phase III and IV clinical trials for cognition in schizophrenia
Talpos, J. C. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.04.014 · Cited by 13
Enhancement of Oxytocin in the Medial Prefrontal Cortex Reverses Behavioral Deficits Induced by Repeated Ketamine Administration in Mice
Zhu, W., Ding, Z., Zhang, Z., Wu, X. A., Liu, X., Zhang, Y., Li, S., Zhou, L., Tian, G., & Qin, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.723064 · Cited by 10
Approaches to Improve the Quantitation of Oxytocin in Human Serum by Mass Spectrometry
Hering, A., Jieu, B., Jones, A., & Muttenthaler, M. (2022) · Frontiers in Chemistry · doi:10.3389/fchem.2022.889154 · Cited by 9
Preliminary evidence that oxytocin does not improve mentalizing in women with schizophrenia
Bradley, E., Tai, M. L., Hankin, M., & Woolley, J. D. (2020) · Hormones and Behavior · doi:10.1016/j.yhbeh.2020.104915 · Cited by 9
Impact of long‐term institutionalization on experiential pleasure and motivation in patients with schizophrenia
Chu, M., Hu, H., Ni, H., Lu, W., Lui, S. S. Y., Yi, Z.-H., Cheung, E. F. C., & Chan, R. C. K. (2019) · PsyCh Journal · doi:10.1002/pchj.300 · Cited by 9
Antipsychotic lurasidone: Behavioural and pharmacokinetic data in C57BL/6 mice
Percelay, S., Since, M., Lagadu, S., Fréret, T., Bouët, V., & Boulouard, M. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172933 · Cited by 8
Rodent models of genetic and chromosomal variations in psychiatric disorders
Nomura, J., Kannan, G., & Takumi, T. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12524 · Cited by 9
Toward effective oxytocin interventions in autism: Overcoming challenges and harnessing opportunities
Ricchiuti, G., Tuerlinckx, E., Taillieu, A., Prinsen, J., Steyaert, J. G., Boets, B., & Alaerts, K. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811241309621 · Cited by 8
Effects of ulotaront on brain circuits of reward, working memory, and emotion processing in healthy volunteers with high or low schizotypy
Perini, F., Nazimek, J. M., McKie, S., Capitão, L. P., Scaife, J. C., Pal, D., Browning, M. D., Dawson, G. R., Nishikawa, H., Campbell, U. C., et al. (2023) · Schizophrenia · doi:10.1038/s41537-023-00385-6 · Cited by 8
Oxytocin enhances the triangular association among behavior, resting‐state, and task‐state functional connectivity
Zhang, H., Chen, K., Bao, J., & Wu, H. (2023) · Human Brain Mapping · doi:10.1002/hbm.26498 · Cited by 7
The Effects of Augmenting Clozapine with Oxytocin in Schizophrenia: An Initial Case Series
Marotta, R. F., Buono, F. D., Garakani, A., Collins, E. D., Cerrito, B., & Rowe, D. (2020) · Annals of Clinical Psychiatry · doi:10.1177/104012372003200211 · Cited by 7
From Parental Behavior to Sexual Function: Recent Advances in Oxytocin Research
Dale, J. K., Harberson, M. T., & Hill, J. W. (2024) · Current Sexual Health Reports · doi:10.1007/s11930-024-00386-1 · Cited by 7
Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia
Piotrowska, D., Potasiewicz, A., Popik, P., & Nikiforuk, A. (2023) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2023.09.005 · Cited by 7
Lipid-based nanostructures in targeted management of neurological disorders: A comprehensive review
Guleria, M., Kamble, A., Upadhyay, M., Sethi, P., Patel, M. B., Malhan, A., Rastogi, S., Datta, D., Singh, S. A., & Prajapati, B. G. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.126530 · Cited by 6
Opinion: Real-Time fMRI Neurofeedback and the Application of the Neuropeptide Oxytocin as Promising New Treatment Approaches in Internet Addiction?
Becker, B., & Montag, C. (2017) · Studies in neuroscience, psychology and behavioral economics · doi:10.1007/978-3-319-46276-9_18 · Cited by 5
The oxytocin system mediates behavioral and neurobiological alterations associated with early adversity
Municchi, D., Mancini, C., Nutarelli, S., Tiberi, M., D’Addario, S. L., Chila, G., Passeri, A., Massa, G., Segni, M. D., Babicola, L., et al. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03437-8 · Cited by 4
Investigation and Analysis of Emotional State and Oxytocin Level in Patients with Postpartum Depression
Yu, X., Zhang, W., & Gao, Y. (2024) · Actas Españolas de Psiquiatría · doi:10.62641/aep.v52i3.1627 · Cited by 5
Add-on Oxytocin in the Treatment of Postpartum Acute Schizophrenia: A Case Report
Medved, S., Janović, M. B., Štimac, Z., & Mihaljević-Peleš, A. (2021) · Journal of Psychiatric Practice · doi:10.1097/pra.0000000000000557 · Cited by 4
Update on Oxytocin, Phosphodiesterase, Neurokinin, Glycine as a Therapeutic Approach in the Treatment of Schizophrenia
Doshi, G., Bhatia, N. Y., Ved, H. S., Pandya, A., Kulkarni, D., Naik, J., Bandiwadekar, T., Godad, A. P., & Kale, P. P. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220817161035 · Cited by 3
Contrasting Effects of Oxytocin on MK801-Induced Social and Non-Social Behavior Impairment and Hyperactivity in a Genetic Rat Model of Schizophrenia-Linked Features
Sampedro-Viana, D., Cañete, T., Ancil-Gascón, P., Cisci, S., Tobeña, A., & Fernández‐Teruel, A. (2024) · Brain Sciences · doi:10.3390/brainsci14090920 · Cited by 3
Epigenetic Control in Schizophrenia
D’Addario, C., & Bartolomeo, M. D. (2025) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-031-75980-2_5 · Cited by 3
Serum Oxytocin Concentration in Patients Receiving Electroconvulsive Therapy
Barhale, C., Raju, M. S. V. K., Pawar, A. V., Kadam, K., Sousa, A. D., & Andrade, C. (2017) · Journal of Ect · doi:10.1097/yct.0000000000000388 · Cited by 3
Intranasal Oxytocin in Pediatric Populations: Exploring the Potential for Reducing Irritability and Modulating Neural Responses: A Mini Review
Sorenson, K., Kendall, E., Grell, H., Kang, M., Shaffer, C. L., & Hwang, S. (2023) · Journal of Psychiatry and Brain Science · doi:10.20900/jpbs.20230008 · Cited by 3
Receptor for advanced glycation end-products and child neglect in mice: A possible link to postpartum depression
Higashida, H., Gerasimenko, M., & Yamamoto, Y. (2022) · Comprehensive Psychoneuroendocrinology · doi:10.1016/j.cpnec.2022.100146 · Cited by 3
Oxytocin and postpartum depression - a possible treatment for depressed mothers
Leziak, M., Niedobylski, S., Żak, K., Piwoński, M., Krasowska, D., & Skórzyńska-Dziduszko, K. (2020) · Journal of Education Health and Sport · doi:10.12775/jehs.2020.10.07.016 · Cited by 2
A new two-hit animal model for schizophrenia research: Consequences on social behavior
Hakenova, K., Mikulecká, A., Holubová, K., Chvojková, M., Šlamberová, R., Jur̀čovičová, J., Čechová, B., Poništ, S., Horáček, J., & Valeš, K. (2025) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2025.05.012 · Cited by 4
Trust and Oxytocin
Yan, Z., & Kirsch, P. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108770880.018 · Cited by 2
External stress, formaldehyde, and schizophrenia: a new mouse model for mental illness research
Cheng, J., Sun, Z., Zhang, H., Zhao, D., Wang, P., Chen, H., Lyv, W., Deng, Q., Fu, Y., Lyv, X., et al. (2025) · Schizophrenia · doi:10.1038/s41537-025-00603-3 · Cited by 1
Integrated Bioinformatics Analyses of Peripheral Blood Transcriptomes Reveals Shared Molecular Features Underlying the Comorbidity of Schizophrenia and Metabolic Syndrome
Zhang, Y., Hao, M., & Hu, Y. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02431-7 · Cited by 1
The role of oxytocin in the pathogenesis and treatment of schizophrenia
Jusiak, K., Brudkowska, Ż., Gołębiowska, M., Morylowska-Topolska, J., Gołębiowska, B., Próchnicki, M., Próchnicka, A., & Karakuła‐Juchnowicz, H. (2017) · Current Problems of Psychiatry · doi:10.1515/cpp-2017-0023 · Cited by 1
Posterior pituitary neurohormonal disturbances in schizophrenia and role of oxytocin in treatment – need for more short- and long-term studies
Gul, O., Gul, S., & Aziz, A. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s183645 · Cited by 1

Authors: Feifel, D., Shilling, P. D., & MacDonald, K.
Affiliations: University of California San Diego (US)
Corresponding author: Feifel, David
ORCID: Feifel, David
Shilling, Paul D.
Venue: Biological Psychiatry
Publisher: Elsevier BV
Published: 2016-02
Volume: 79
Issue: 3
Pages: 222-233
ISSN: 0006-3223 (ISSN-L)
DOI: 10.1016/j.biopsych.2015.07.025
PMC: PMC5673255
OpenAlex: W1441608289
Cited by: 110
References: 132
Citations by year: 2026: 2 · 2025: 8 · 2024: 4 · 2023: 5 · 2022: 10 · 2021: 12 · 2020: 11 · 2019: 11 · 2018: 10 · 2017: 17 · 2016: 18
FWCI: 2.15
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Biological Psychiatry (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: Goodenough Neuroscience Research Fund
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords: oxytocin, schizophrenia, positive symptoms, negative symptoms, cognitive impairment, oxytocinergic system, antipsychotic drugs, new drugs, schizophrenia spectrum disorders
MeSH terms: Animals, Brain, Cognition, Cognition Disorders, Disease Models, Animal, Humans, Oxytocin, Schizophrenia, Schizophrenic Psychology

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Review of Oxytocin’s Effects on the Positive, Negative, and Cognitive Domains of Schizophrenia

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks